Dr. Katz leads the Cancer Surveillance & Outcomes Research Team (www.cansort.org), an interdisciplinary group of investigators dedicated to researching cancer quality of care. Our investigators are located at five universities and cancer centers throughout the United States and seek to understand and improve how patients and their providers communicate and make decisions about cancer treatments. CanSORT studies the quality of cancer care across the continuum of care from prevention to survivorship. The team also develops and evaluates interventions to improve cancer care including decision tools for patients and clinicians and dissemination strategies to more quickly move research results to the provider community.
Katz SJ, Wallner LP, Abrahamse PH, Janz NK, Martinez KA, Shumway DA, Hamilton AS, Ward KC, Resnicow KA, Hawley ST. Cancer 2017 Aug 15;123(16):3022-3030.
Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
Kurian AW, Li Y, Hamilton AS, Ward KC, Hawley ST, Morrow M, McLeod MC, Jagsi R, Katz SJ. J Clin Oncol July 2017; 35:20, 2232-2239.
Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer
Katz SJ, Janz NK, Abrahamse P, Wallner LP, Hawley ST, An LC, Ward KC, Hamilton AS, Morrow M, Jagsi R. JAMA Surg 2017 July 1;152(7):658-664.
Kurian AW, Griffith KA, Hamilton AS, Ward KC, Morrow M, Katz SJ, Jagsi R. JAMA Feb 2017; 317(5):531-534.
Chemotherapy Decisions and Patient Experience With the Recurrence Score Assay for Early-Stage Breast Cancer
Friese CR, Li Y, Bondarenko I, Hofer TP, Ward KC, Hamilton AS, Deapen D, Kurian AW, Katz SJ. Cancer Jan 2017; 123(1):43-51.